APREPITANT 125 MG CAPSULE

aprepitant
$117.0810per EA

Strength

125 mg/1

Manufacturer

Sandoz Inc.

NDC

00781232368

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

APREPITANT

Approval Type

Generic (ANDA)

FDA Application

ANDA090999

On Market Since

12/27/2016

Pharmacological Classes

Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist

Price History

1W

0.0%

1M

-3.4%

3M

-19.1%

6M

-34.4%

1Y

-32.1%

3Y

N/A

5Y

N/A

All

-35.7%